Liposomes as a delivery system for membrane-active antitumor drugs
- 31 January 1990
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 11 (1-3) , 225-232
- https://doi.org/10.1016/0168-3659(90)90135-g
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Liposomes in cancer therapyAdvanced Drug Delivery Reviews, 1989
- A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Multidrug Resistance1JNCI Journal of the National Cancer Institute, 1988
- REDUCTION IN TOXICITY OF DOXORUBICIN BY LIPOSOMAL ENTRAPMENTThe Lancet, 1987
- Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cellsBritish Journal of Cancer, 1987
- The cell biology of multiple drug resistanceBiochemical Pharmacology, 1987
- Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinomaBritish Journal of Cancer, 1986
- Genetic and biochemical characterization of multidrug resistancePharmacology & Therapeutics, 1985
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983
- Liposomes—Problems and promise as selective drug carriersCancer Treatment Reviews, 1981